The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7422-7429

  Sá Nunes, Anderson ^a,b   Bafica, André ^c   Antonelli, Lis R ^b   Choi, Eun Young ^d   Francischetti, Ivo M B ^b   Andersen, John F ^b   Shi, Guo Ping ^e   Chavakis, Triantafyllos ^d   Ribeiro, José M ^b   Kotsyfakis, Michalis ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d NATIONAL CANCER INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CATHEPSIN S; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 17; PROTEINASE INHIBITOR; SIALOSTATIN L; UNCLASSIFIED DRUG; ANTIGEN; CATHEPSIN; CYSTATIN; CYTOKINE; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; SIALOSTATIN L, IXODES SCAPULARIS;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG PROTEIN BINDING; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; IXODES; METABOLISM; MIXED LYMPHOCYTE CULTURE; MOUSE MUTANT; PROTEIN BINDING;

ANIMALS; ANTIGENS; AUTOIMMUNITY; CATHEPSINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYSTATINS; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; FEMALE; IXODES; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, KNOCKOUT; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 67649172594     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900075     Document Type: Article

References (46)

1. Titus, R. G., and J. M. Ribeiro. 1990. The role of vector saliva in transmission of arthropod-borne disease. Parasitol Today. 6: 157-160.
2. Hill, C. A., and S. K. Wikel. 2005. The Ixodes scapularis Genome Project: an opportunity for advancing tick research. Trends Parasitol. 21: 151-153.
3. Center for Disease Control and Prevention. 2004. Lyme disease - United States, 2001-2002. Morbid. Mortal. Wkly. Rep. 53: 107-113.
4. Ramachandra, R. N., and S. K. Wikel. 1992. Modulation of host-immune responses by ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production. J. Med. Entomol. 29: 818-826.
5. Zeidner, N., M. L. Mbow, M. Dolan, R. Massung, E. Baca, and J. Piesman. 1997. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect. Immun. 65: 3100-3106.
6. Schoeler, G. B., S. A. Manweiler, and S. K. Wikel. 2000. Cytokine responses of C3H/HeN mice infested with Ixodes scapularis or Ixodes pacificus nymphs. Parasite Immunol. 22: 31-40.
7. Ferreira, B. R., and J. S. Silva. 1999. Successive tick infestations selectively promote a T-helper 2 cytokine profile in mice. Immunology 96: 434-439.
8. Borsky, I., J. Hermanek, J. Uhlir, and F. Dusbabek. 1994. Humoral and cellular immune response of BALB/c mice to repeated infestations with Ixodes ricinus nymphs. Int. J. Parasitol. 24: 127-132.
9. Macaluso, K. R., and S. K. Wikel. 2001. Dermacentor andersoni: effects of repeated infestations on lymphocyte proliferation, cytokine production, and adhesion-molecule expression by BALB/c mice. Ann. Trop. Med. Parasitol. 95: 413-427.
10. 2-dependent mechanism. J. Exp. Med. 180: 1077-1085.
11. Ferreira, B. R., and J. S. Silva. 1998. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-γ-induced macrophage microbicidal activity. Vet. Immunol. Immunopathol. 64: 279-293.
12. Mejri, N., B. Rutti, and M. Brossard. 2002. Immunosuppressive effects of Ixodes ricinus tick saliva or salivary gland extracts on innate and acquired immune response of BALB/c mice. Parasitol. Res. 88: 192-197.
13. Ribeiro, J. M., G. T. Makoul, J. Levine, D. R. Robinson, and A. Spielman. 1985. Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J. Exp. Med. 161: 332-344.
14. 2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 179: 1497-1505.
15. Bergman, D. K., M. J. Palmer, M. J. Caimano, J. D. Radolf, and S. K. Wikel. 2000. Isolation and molecular cloning of a secreted immunosuppressant protein from Dermacentor andersoni salivary gland. J. Parasitol. 86: 516-525.
16. Leboulle, G., M. Crippa, Y. Decrem, N. Mejri, M. Brossard, A. Bollen, and E. Godfroid. 2002. Characterization of a novel salivary immunosuppressive protein from Ixodes ricinus ticks. J. Biol. Chem. 277: 10083-10089.
17. Gillespie, R. D., M. C. Dolan, J. Piesman, and R. G. Titus. 2001. Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J. Immunol. 166: 4319-4326.
18. + T cell activation. Immunity 16: 849-859.
19. Garg, R., I. J. Juncadella, N. Ramamoorthi, Ashish, S. K. Ananthanarayanan, V. Thomas, M. Rincon, J. K. Krueger, E. Fikrig, C. M. Yengo, and J. Anguita. 2006. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J. Immunol. 177: 6579-6583.
20. Kotsyfakis, M., A. Sa-Nunes, I. M. Francischetti, T. N. Mather, J. F. Andersen, and J. M. Ribeiro. 2006. Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis. J. Biol. Chem. 281: 26298-26307.
21. Kotsyfakis, M., S. Karim, J. F. Andersen, T. N. Mather, and J. M. Ribeiro. 2007. Selective cysteine protease inhibition contributes to blood-feeding success of the tick Ixodes scapularis. J. Biol. Chem. 282: 29256-29263.
22. Zavasnik-Bergant, T., and B. Turk. 2006. Cysteine cathepsins in the immune response. Tissue Antigens 67: 349-355.
23. Hsing, L. C., and A. Y. Rudensky. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207: 229-241.
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
25. Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202: 1715-1724.
26. Ahmed, S. A., R. M. Gogal, Jr., and J. E. Walsh. 1994. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods 170: 211-224.
27. Xie, C., P. Alcaide, B. V. Geisbrecht, D. Schneider, M. Herrmann, K. T. Preissner, F. W. Luscinskas, and T. Chavakis. 2006. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J. Exp. Med. 203: 985-994.
28. Thurmond, R. L., S. Sun, C. A. Sehon, S. M. Baker, H. Cai, Y. Gu, W. Jiang, J. P. Riley, K. N. Williams, J. P. Edwards, and L. Karlsson. 2004. Identification of a potent and selective noncovalent cathepsin S inhibitor. J. Pharmacol. Exp. Ther. 308: 268-276.
29. Shi, G. P., J. A. Villadangos, G. Dranoff, C. Small, L. Gu, K. J. Haley, R. Riese, H. L. Ploegh, and H. A. Chapman. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10: 197-206.
30. Pierre, P., and I. Mellman. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93: 1135-1145.
31. Dittel, B. N., I. Visintin, R. M. Merchant, and C. A. Janeway, Jr. 1999. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163: 32-39.
32. Villadangos, J. A., R. A. Bryant, J. Deussing, C. Driessen, A. M. Lennon-Dumenil, R. J. Riese, W. Roth, P. Saftig, G. P. Shi, H. A. Chapman, et al. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172: 109-120.
33. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadangos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4: 357-366.
34. Riese, R. J., R. N. Mitchell, J. A. Villadangos, G. P. Shi, J. T. Palmer, E. R. Karp, G. T. De Sanctis, H. L. Ploegh, and H. A. Chapman. 1998. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101: 2351-2363.
35. Diment, S. 1990. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 145: 417-422. (Pubitemid 20252343)
36. Baxter, A. G. 2007. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7: 904-912.
37. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
38. Segal, B. M., and E. M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184: 771-775.
39. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181: 381-386.
40. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
41. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
42. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541.
43. Nakagawa, T. Y., W. H. Brissette, P. D. Lira, R. J. Griffiths, N. Petrushova, J. Stock, J. D. McNeish, S. E. Eastman, E. D. Howard, S. R. Clarke, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10: 207-217.
44. Saegusa, K., N. Ishimaru, K. Yanagi, R. Arakaki, K. Ogawa, I. Saito, N. Katunuma, and Y. Hayashi. 2002. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110: 361-369.
45. Podolin, P. L., B. J. Bolognese, D. C. Carpenter, T. G. Davis, R. A. Johanson, J. H. Fox, E. Long III, X. Dong, R. W. Marquis, S. M. Locastro, et al. 2008. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor. J. Immunol. 180: 7989-8003.
46. Gupta, S., R. K. Singh, S. Dastidar, and A. Ray. 2008. Cysteine cathepsin S as an immunomodulatory target: present and future trends. Expert Opin. Ther. Targets 12: 291-299.